Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
Evelo Biosciences Psoriasis Candidate Shows Benefit In Mid-Stage Study
September 27, 2021
Tickers
EVLO
From Benzinga
Kids Suffer Adverse Reactions In Applied Genetic's Color Blindness Gene Therapy Trial
September 24, 2021
Tickers
AGTC
From Benzinga
Capricor Stock Is Moving Higher As Duchenne Dystrophy Cell Therapy Slows Disease Progression By 71%
September 24, 2021
Tickers
CAPR
From Benzinga
GlycoMimetics' Lead Candidate Data Published In An Online Journal
September 24, 2021
Tickers
GLYC
From Benzinga
Vietnam's Health Ministry Approves Phase 2, Phase 3 Cohorts Of Arcturus' COVID-19 Vaccine Trial
September 22, 2021
Tickers
ARCT
From Benzinga
Why Are Dynavax Technologies Shares Skyrocketing Today?
September 22, 2021
Tickers
DVAX
From Benzinga
AIM ImmunoTech Receives Positive FDA Response For Ampligen Trial In PCCD Patients
September 21, 2021
Tickers
AIM
From Benzinga
Seelos Therapeutics Shares Gain On FDA Approval To Add SLS-005 Regimen In HEALEY ALS Trial
September 21, 2021
Tickers
SEEL
From Benzinga
Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO
September 21, 2021
Tickers
APRE
From Benzinga
Ocugen's India-Based Partner Concludes COVID-19 Vaccine Trials In Children: Report
September 21, 2021
Tickers
OCGN
From Benzinga
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
September 20, 2021
From Benzinga
Edesa Biotech Stock Is Rallying After COVID-19 Antibody Data: What You Need To Know
September 20, 2021
Tickers
EDSA
From Benzinga
Mirati Unveils Long-term Survival Data For Sitravatinib/Nivolumab Combo In Lung Cancer Patients
September 20, 2021
From Benzinga
Mirati Posts Adagrasib Data In KRAS-Mutated Lung Cancer, FDA Filing Now On The Cards
September 20, 2021
Tickers
MRTX
From Benzinga
Why Are Synlogic Shares Moving Higher Premarket Monday?
September 20, 2021
Tickers
SYBX
From Benzinga
From Benzinga
AstraZeneca-Daiichi Sankyo Share Detailed Enhertu Data In Gastric Cancer
September 17, 2021
From Benzinga
Corcept Therapeutics' Relacorilant Combo Therapy Shows Clinical Benefit In Ovarian Cancer
September 17, 2021
Tickers
CORT
From Benzinga
What Is Happening With Innate Pharma Stock On Friday?
September 17, 2021
From Benzinga
Agenus' Combo Therapy Trial Shows Higher Responses In Cervical Cancer
September 17, 2021
Tickers
AGEN
From Benzinga
Ayala Pharma Unveils New Interim Data From Rare Cancer Trial With AL101
September 16, 2021
Tickers
AYLA
From Benzinga
Biogen Reports Mixed Phase 2 Data For Its Non-Opioid Pain Candidate
September 16, 2021
Tickers
BIIB
From Benzinga
Zymeworks' Zanidatamab Aces Mid-Stage Esophageal Cancer Trial
September 16, 2021
From Benzinga
Leap Therapeutics Stock Is Moving Higher On Updated DKN-01 Combo Trial Data In Gastric Cancer
September 16, 2021
From Benzinga
Aerie Pharma Reports Mixed Bag On Phase 2 Dry Eye Trial
September 16, 2021
Tickers
AERI
From Benzinga
Hookipa Pharma, Merck Team Up For Phase 2 Head & Neck Cancer Trial
September 15, 2021
From Benzinga
What's Happening With RedHill Biopharma's Stock On Tuesday?
September 14, 2021
Tickers
RDHL
From Benzinga
FDA Lifts Clinical Hold On KalVista's Hereditary Angioedema Trial
September 14, 2021
Tickers
KALV
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
